14-Deoxyandrographolide alleviates ethanol-induced hepatosteatosis through stimulation of AMP-activated protein kinase activity in rats

Alcohol

Volumn 48, Issue 2, 2014, Pages 123-132

  Mandal, Samir ^a   Mukhopadhyay, Sibabrata ^a   Bandhopadhyay, Sukdeb ^a   Sen, Gargi ^b   Biswas, Tuli ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Chemistry Division CSIR Indian Institute of Chemical Biology ^*  (India)

Author keywords

14 Deoxyandrographolide; AMP activated protein kinase; Ethanol; Hepatosteatosis; Lipid metabolism

Indexed keywords

14 DEOXYANDROGRAPHOLIDE; ADENYLATE CYCLASE; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DITERPENOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRTUIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; LIVER TOXICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANDROGRAPHIS PANICULATA; ANIMALIA; RATTUS;

14-DEOXYANDROGRAPHOLIDE; AMP-ACTIVATED PROTEIN KINASE; ETHANOL; HEPATOSTEATOSIS; LIPID METABOLISM;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DITERPENES; DOWN-REGULATION; ETHANOL; FATTY LIVER, ALCOHOLIC; FEMALE; HEP G2 CELLS; HUMANS; LIPID METABOLISM; RATS; RATS, SPRAGUE-DAWLEY; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UP-REGULATION;

EID: 84896048051     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2013.11.005     Document Type: Article

References (50)

1. Abu-Elheiga L., Matzuk M.M., Kordari P., Oh W., Shaikenov T., Gu Z., et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12011-12016.
2. Bhattacharyya K., Kar T., Bocelli G., Cantoni A., Pramanick S., Banerjee S., et al. Redetermination of 14-deoxyandrographolide. Acta Crystallographica 2005, E61:o2743-o2745.
3. Bradham C.A., Plümpe J., Manns M.P., Brenner D.A., Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. The American Journal of Physiology 1998, 275:G387-G392.
4. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation 2004, 114:147-152.
5. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metabolism 2005, 1:309-322.
6. Chandler C.E., Wilder D.E., Pettini J.L., Savoy Y.E., Petras S.F., Chang G., et al. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. Journal of Lipid Research 2003, 44:1887-1901.
7. Deng W.L., Nie R.J., Liu J.Y. Comparison of pharmacological effects of four andrographolides. Chinese Pharmcological Bulletin 1982, 17:195-198.
8. Dyck J.R., Kudo N., Barr A.J., Davies S.P., Hardie D.G., Lopaschuk G.D. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. European Journal of Biochemistry 1999, 262:184-190.
9. Endo M., Masaki T., Seike M., Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Experimental Biology and Medicine 2007, 232:614-621.
10. Feingold K.R., Adi S., Staprans I., Moser A.H., Neese R., Verdier J.A., et al. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. The American Journal of Physiology 1990, 259:E177-E184.
11. Feingold K.R., Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat invivo. The Journal of Clinical Investigation 1987, 80:184-190.
12. Follstad B.D., Wang D.I., Stephanopoulos G. Mitochondrial membrane potential differentiates cells resistant to apoptosis in hybridoma cultures. European Journal of Biochemistry 2000, 267:6534-6540.
13. Foufelle F., Ferré P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. The Biochemical Journal 2002, 366:377-391.
14. Fryer L.G., Carling D. AMP-activated protein kinase and the metabolic syndrome. Biochemical Society Transactions 2005, 33:362-366.
15. Fujita T., Fujitani R., Takeda Y., Takaishi Y., Yamada T., Kido M., et al. On the diterpenoids of Andrographis paniculata: X-ray crystallographic analysis of andrographolide and structure determination of new minor diterpenoids. Chemical & Pharmaceutical Bulletin 1984, 32:2117-2125.
16. Gerhart-Hines Z., Dominy J.E., Blättler S.M., Jedrychowski M.P., Banks A.S., Lim J.H., et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Molecular Cell 2011, 44:851-863.
17. Girard J., Perdereau D., Foufelle F., Prip-Buus C., Ferré P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB Journal 1994, 8:36-42.
18. Girish C., Pradhan S.C. Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice. Journal of Pharmacology & Pharmacotherapeutics 2012, 3:149-155.
19. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2005, 2:9-19.
20. Hutchinson D.S., Chernogubova E., Dallner O.S., Cannon B., Bengtsson T. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 2005, 48:2386-2395.
21. Kelly M., Gauthier M.S., Saha A.K., Ruderman N.B. Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes 2009, 58:1953-1960.
22. Lieber C.S., DeCarli L.M., Sorrell M.F. Experimental methods of ethanol administration. Hepatology 1989, 10:501-510.
23. Lindros K.O., Penttilä K.E. Digitonin-collagenase perfusion for efficient separation of periportal or perivenous hepatocytes. The Biochemical Journal 1985, 228:757-760.
24. Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metabolism 2011, 13:376-388.
25. McKnight G.S., Cummings D.E., Amieux P.S., Sikorski M.A., Brandon E.P., Planas J.V., et al. Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Progress in Hormone Research 1998, 53:139-159.
26. de Meijer V.E., Sverdlov D.Y., Popov Y., Le H.D., Meisel J.A., Nosé V., et al. Broad-spectrum matrix metalloproteinase inhibition curbs infl{ligature}ammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One 2010, 5:e11256-e11269.
27. Memon R.A., Grunfeld C., Moser A.H., Feingold K.R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993, 132:2246-2253.
28. Nanji A.A., Mendenhall C.L., French S.W. Beef fat prevents alcoholic liver disease in the rat. Alcoholism: Clinical and Experimental Research 1989, 13:15-19.
29. Natali F., Siculella L., Salvati S., Gnoni G.V. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. Journal of Lipid Research 2007, 48:1966-1975.
30. Negi A.S., Kumar J.K., Luqman S., Shanker K., Gupta M.M., Khanuja S.P. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Medicinal Research Reviews 2008, 28:746-772.
31. Nin V., Escande C., Chini C.C., Giri S., Camacho-Pereira J., Matalonga J., et al. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase. The Journal of Biological Chemistry 2012, 287:23489-23501.
32. Purohit V., Gao B., Song B.J. Molecular mechanisms of alcoholic fatty liver. Alcoholism: Clinical and Experimental Research 2009, 33:191-205.
33. Raghow R., Yellaturu C., Deng X., Park E.A., Elam M.B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends in Endocrinology and Metabolism 2008, 19:65-73.
34. Roy D.N., Mandal S., Sen G., Mukhopadhyay S., Biswas T. 14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway. British Journal of Pharmacology 2010, 160:1823-1843.
35. Ruderman N.B., Saha A.K., Vavvas D., Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. The American Journal of Physiology 1999, 276:E1-E18.
36. Shen Z., Liang X., Rogers C.Q., Rideout D., You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 2010, 298:G364-G374.
37. Siripong P., Kongkathip B., Preechanukool K., Picha P., Tunsuwan K., Taylor W.C. Cytotoxic diterpenoid constituents from Andrographis paniculata Nees leaves. Journal of the Science Society of Thailand 1992, 18:187-194.
38. Steinberg G.R., Macaulay S.L., Febbraio M.A., Kemp B.E. AMP-activated protein kinase-the fat controller of the energy railroad. Canadian Journal of Physiology and Pharmacology 2006, 84:655-665.
39. Steinberg G.R., Michell B.J., van Denderen B.J., Watt M.J., Carey A.L., Fam B.C., et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metabolism 2006, 4:465-474.
40. Tan M.L., Kuroyanagi M., Sulaiman S.F., Najimudin N., Tengku Muhammad T.S. Cytotoxic activities of major diterpenoid constituents of Andrographis paniculata in a panel of human tumor cell lines. Pharmaceutical Biology 2005, 43:501-508.
41. Thampy K.G., Wakil S.J. Activation of acetyl-CoA carboxylase. Purification and properties of a Mn2+-dependent phosphatase. The Journal of Biological Chemistry 1985, 260:6318-6323.
42. Thurman R.G., Bradford B.U., Iimuro Y., Knecht K.T., Arteel G.E., Yin M. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. Journal of Gastroenterology and Hepatology 1998, 13:S39-S50.
43. Tomas E., Tsao T.S., Saha A.K., Murrey H.E., Zhang Cc C., Itani S.I., et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16309-16313.
44. Unger R.H. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 2004, 117:145-146.
45. Woods A., Dickerson K., Heath R., Hong S.P., Momcilovic M., Johnstone S.R., et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2005, 2:21-33.
46. Xiao Y.F., Wu D.D., Liu S.X., Chen X., Ren L.F. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World Journal Gastroenterology 2007, 13:6498-6505.
47. Yin W., Mu J., Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. The Journal of Biological Chemistry 2003, 278:43074-43080.
48. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
49. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. The Journal of Biological Chemistry 2004, 279:47898-47905.
50. Zhou Z., Wang L., Song Z., Lambert J.C., McClain C.J., Kang Y.J. Acritical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. The American Journal of Pathology 2003, 163:1137-1146.